Alkem Laboratories Limited has informed the Exchange regarding a press release dated January 08, 2026, titled "Alkem launches Renocia cyclical therapy, a nutritional supplements kit, to support hair growth".
ALKEM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Alkem Laboratories has launched Renocia cyclical therapy, a new nutritional supplements kit designed to support hair growth, strengthen hair follicles, and manage hair loss. The kit is a weekly regimen of vitamins, minerals, and amino acids with separate formulations for men and women, made using vegetarian-sourced ingredients. It is a prescription product sold in a four-week wallet pack. This launch expands Alkem's existing Renocia hair care range, which already includes shampoo, conditioner, serum, and oral supplements, and strengthens its dermatology portfolio.
This is a routine product line extension within Alkem's dermatology segment and is unlikely to materially move the stock. It supports the company's diversification beyond its core anti-infective, gastrointestinal, and pain management therapies, but no financial impact or revenue guidance was provided.